Biologic activities of IL-1 and its role in human disease

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 3, 1998, Pages 344-350

  Rosenwasser, Lanny J ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ALLERGIC DISEASE; CANCER INHIBITION; CELL MATURATION; CORONARY ARTERY ATHEROSCLEROSIS; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; DRUG MECHANISM; GENE EXPRESSION; HEMATOPOIESIS; HOST RESISTANCE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INFLAMMATION; LUNG INJURY; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TERTIARY STRUCTURE; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0031691352     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70118-6     Document Type: Article

References (47)

1. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-147.
2. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-52.
3. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993;328:106-13.
4. Arend WP. Interleukin-1 receptor antagonist. Adv Immunol 1993;54:167-227.
5. Ohisson K, Bjork P, Bergenfeidt M, Hageman R, Thompson RC. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990;348:550-2.
6. Auron PE, Webb AC. Interleukin-1: a gene expression system regulated at multiple levels. Eur Cytokine Netw 1994;5:573-92.
7. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Gin JG, et al. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA 1993;90:6155-9.
8. Re F, Muzio M, DeRossi M, Polentarutti N, Giri JG, Mantovani A, et al. The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med 1994;179:739-43.
9. Gehrke L, Jobling SA, Paik LSK, McDonald B, Rosenwasser LJ, Auron PE. A point mutation uncouples human interleukin-1β biological activity and receptor binding. J Biol Chem 1990;265:5922-5.
10. Ferretti M, Casini-Raggi V, Pizarro TT, Eisenberg SP, Nast CC, Cominelli F. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J Clin Invest 1994;94:449-53.
11. Buras JA, Reenstra WR, Fenton MJ. NFβA, a factor required for maximal interleukin-1β gene expression is identical to the ets family member PU.1. Evidence for structural alteration following LPS activation. Mol Immunol 1995;32:541-54.
12. Kominato Y, Galson DL, Waterman WR, Webb AC, Auron PE. Monocyte expression of the human prointerleukin-1b (IL1B) gene is dependent on promoter sequences which bind the hematopoietic transcription factor Spi/PU.1. Mol Cell Biol 1995;15:59-68.
13. Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickett KS, et al. Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 1988;263:9437-42.
14. Wilson KP, Black JA, Thomson JA, Kim EE, Griffith JP, Navia MA, et al. Structure and mechanism of interleukin-1β converting enzyme. Nature 1994;370:270-5.
15. Walker NP, Talanian RV, Brady KD, Dang LC, Bump NJ, Ferenz CR, et al. Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer. Cell 1994;78:343-52.
16. Auron PE, Quigley GJ, Rosenwasser LJ, Gehrke L. Multiple amino acid substitutions suggest a structural basis for the separation of biological activity and receptor binding in a mutant interleukin-1β protein. Biochem 1992;31:6632-8.
17. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JWM, et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990;161:79-84.
18. Granowitz EV, Clark BD, Mancilla J, Dinarello CA. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem 1991;266:14147-50.
19. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265-71.
20. Vannier E, Miller LC, Dinarello CA. Coordinated anti-inflammatory effect of IL-4: interleukin-4 suppresses IL-1 production but up regulates gene expression and synthesis of IL-1ra. Proc Natl Acad Sci USA 1992;89:4076-80.
21. 2 receptors. J Exp Med 1991;174:281-4.
22. Vannier E, Lefort J, Lellouch-Tubiana A, Terlain B, Vargaftig BB. Lipopolysaccharide from E. coli reduces antigen-induced bronchocon-striction in actively sensitized guinea pigs. J Clin Invest 1991;87:1936-44.
23. 2 receptors in peripheral blood mononuclear cells. J Biol Chem 1994;269:9952-6.
24. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
25. Andersson CE, Lönnroth IC, Gelin LJ, Moldawer LL, Lundholm KG. Pretranslational regulation of albumin synthesis in tumor-bearing mice. The role of anorexia and undernutrition. Gastroenterology 1991;100:938-45.
26. Gershenwald JE, Fong YM, Fahey TJ, Calvano SE, Chizzonite R, Kilian PL, et al. Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci USA 1990;87:4966-70.
27. Smith JW, Longo D, Alvord WG, Janik JE, Sharfman WH, Gause BL, et al. The effects of treatment with interleukin-1α on platelet recovery after high-dose carboplatin. N Engl J Med 1993;328:756-61.
28. Neta R, Oppenheim JJ, Wang J-M, Snapper CM, Moorman MA, Dubois CM. Synergy of IL-1 and stem cell factor in radioprotection of mice is associated with IL-1 up-regulation of mRNA and protein expression for c-kit on bone marrow cells. J Immunol 1994;153:1536-43.
29. Shirakawa F, Tanaka Y, Ota T, Eto S, Yamashita U. Autocrine stimulation of interleukin-1α in the growth of adult T cell leukemia cells. Cancer Res 1989;49:1143-7.
30. Mandrup-Poulsen T, Wogensen L, Jensen M, Svensson P, Nilsson P, Emdal T, et al. Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury. Crit Care Med 1995;23:26-33.
31. Warner SJC, Auger KR, Libby P. Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. J Exp Med 1987;165:1316-31.
32. Warner SJC, Auger KR, Libby P. Interleukin-1 induces interleukin-1. II. Recombinant interleukin-1 induces interleukin-1 production by adult human vascular endothelial cells in vitro. J Immunol 1987;139:1911-7.
33. Brody JI, Pickering NJ, Cpuzzi DM, Fink GB, Can CA, Gomez F. Interleukin-1α as a factor in occlusive vascular disease. Am J Clin Pathol 1992;97:8-13.
34. Pearce WH, Sweis I, Yao JS, McCarthy WJ, Koch AE. Interleukin-1β and tumor necrosis factor-α release in normal and diseased human infrarenal aortas. J Vasc Surg 1992;16:784-9.
35. Hawrylowicz CM, Howells GL, Feldmann M. Platelet-derived interleukin-1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med 1991;174:785-90.
36. Sousa AR, Trigg CJ, Lane SJ, Hawksworth R, Nakhosteen JA, Poston RN, et al. Effect of inhaled glucocorticoids on IL-1 beta and IL-2 receptor antagonist (IL-1 ra) expression in asthmatic bronchial epithelium. Thorax 1997;52:407-10.
37. Hastie AT, Everts KB, Cho SK, Zangrilli J, Shaver JR, Pollice MB, et al. IL-1 beta release from cultured bronchial epithelial cells and bron-choalveolar lavage cells from allergic and normal humans following segmental challenge with ragweed. Cytokine 1996;8:730-8.
38. Hakonarson H, Herrick DJ, Serrano PG, Grunstein MM. Autocrine role of interleukin 1 beta in altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J Clin Invest 1997;99:117-24.
39. Sousa AR, Lane SJ, Nakhosteen JA, Lee TH, Poston RN. Expression of interleukin-1 β (IL-1β) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. Am J Respir Crit Care Med 1996;154:1061-6.
40. Shornick LP, De Togni P, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, et al. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzone. J Exp Med 1996;183:1427-36.
41. Ackerman V, Carpi S, Bellini A, Vassalli G, Marini M, Mattoli S. Constitutive expression of endothelin in bronchial epithelial cells of patients with symptomatic and asymptomatic asthma and modulation by histamine and interleukin-1. J Allergy Clin Immunol 1995;96:618-27.
42. Okada S, Inoue H, Yamauchi K. Potential role of interleukin-1 in allergen-induced late asthmatic reactions in guinea pigs: suppressive effect of interleukin-1 receptor antagonist on late asthmatic reaction. J Allergy Clin Immunol 1995;95:1236-45.
43. Manetti R, Barak V, Piccinni MP, Sampognaro S, Parronchi P, Maggi E, et al. Interleukin-1 favours the in vitro development of type 2 T helper (Th2) human T-cell clones. Res Immunol 1994;145:93-100.
44. Borish L, Mascali JJ, Rosenwasser LJ. IgE-dependent cytokine production by human peripheral blood mononuclear phagocytes. J Immunol 1991;146:63-7.
45. Bochner BS, Charlesworth EN, Lichtenstein LM, Derse CP, Gillis S, Dinarello CA, et al. Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol 1990;86:830-9.
46. Borish L, Mascali JJ, Beam WR, Martin RJ, Rosenwasser LJ. Detection of alveolar macrophage-derived interleukin 1β in asthma: inhibition with corticosteroids. J Immunol 1992;149:3078-82.
47. Williams J, Johnson S, Mascali JJ, Smith H, Rosenwasser LJ, Borish L. Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects. J Immunol 1992;149:2823-9.